Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04746924 |
|---|---|
| Brief Title: | A Study of Ociperlimab With Tislelizumab Compared to Pembrolizumab in Participants With Untreated Lung Cancer |
| First Submitted : | February 5, 2021 |
| First Submitted that Met QC Criteria : | February 5, 2021 |
| First Posted : | February 10, 2021 |
| Last Update Submitted that Met QC Criteria : | October 25, 2022 |
| Last Update Posted : | October 27, 2022 |